Related Experiment Video
Updated: May 20, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
The changing landscape of product development and randomized trials
1Center for Clinical Research, Department of Trauma and Orthopaedic Surgery, Unfallkrankenhaus Berlin Trauma Center, Warener Strasse7, 12683 Berlin, Germany. dirk.stengel@ukb.de
The Journal of Bone and Joint Surgery. American Volume
|July 20, 2012
Summary
European regulators now require randomized controlled trials (RCTs) for innovative orthopaedic devices. This necessitates streamlined clinical trial designs to ensure timely evaluation of new implants and enhance patient care.
Area of Science:
- Biomedical Engineering
- Clinical Trials
- Regulatory Science
Background:
- Ongoing debate regarding clinical evaluation standards for orthopaedic implants versus pharmaceuticals.
- Emerging regulatory mandates in Europe require randomized controlled trials (RCTs) for innovative device market approval.
Purpose of the Study:
- To address the evolving landscape of clinical evaluation for orthopaedic devices.
- To propose modifications to streamline clinical trials for orthopaedic implants.
- To emphasize the importance of noninferiority and equivalence trial outcomes.
Main Methods:
- Discussion of the implications of mandatory RCTs for orthopaedic device evaluation.
- Identification of challenges in current orthopaedic clinical trial methodologies.
- Proposal of pragmatic trial designs, lean documentation, and international collaboration.
Main Results:
- Regulatory shifts towards RCTs for innovative orthopaedic devices are anticipated.
- Achieving superiority for new orthopaedic devices over established standards is increasingly rare.
- Noninferiority and equivalence are crucial outcomes for expanding therapeutic options.
Conclusions:
- Substantial changes in clinical trial design and execution are required for orthopaedic devices.
- Streamlined trials, including pragmatic designs and international collaboration, are essential.
- RCTs, supplemented by registry data, are vital for assessing the utility, value, and safety of new implants.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...